20
Nov

Hopes and frustrations

The "Cure Research for t1d" email blast today came with some disheartening news. MK-2640 has been cancelled due to "lack of efficacy."

Not familiar with MK-2640? It is was Merck's Smart Insulin. It has been going through a (slightly modified) phase-1 trial since early 2015.  Not much info seems to be available re: the failure if the drug.
I've been following MK-2640 with a sort of cautious optimism for a few years now. It seemed real and possible and worth investing a bit of hope.
Hope's a bitch sometimes, isn't it?

Back to Top